EdelsonRBergerCGasparroF. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med1987; 316:297–303.
2.
RookACohenJ. Therapeutic applications of photopheresis. Derm Clin1993; 11:339–347.
3.
PepinoPBergerC. Primate cardiac allo and xeno transplantation: Modulation of the immune response with photochemotherapy. Eur Surg Res1989;21:105–113.
4.
CooperJDPattersonGATrulockEP. Results of single and bilateral lung transplantation in 131 consecutive patients. J Thorac Cardiovasc Surg1994; 107:460–470.
5.
TrulockEP. Lung transplantation. Am J Respir Crit Care Med1997; 155:789–818.
6.
KeenanRJKonishiHKawaiA. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg1995; 60:580–584.
7.
RossDJWatersPFLevineM. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: Preliminary experience. J Heart Lung Transplant1998; 17:768–774.
8.
CahillBCO'RourkeMKStrasburgKA. Methotrexate for lung transplant recipients with steroid-resistant acute rejection. J Heart Lung Transplant1996; 1511:1130–1137.
9.
ParadisILYousemSAGriffithBP. Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med1993; 14:751–763.
10.
YousemSA. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am J Surg Path1993; 17:491–496.
11.
EstenneMMaurerJRBoehlerA. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant2002; 21:297–310.
12.
GirgisRETuIBerryGJ. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant1996; 15:1200–1208.
13.
Bonnefoy–BerardNRevillardJP. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. J Heart Lung Transplant1996; 15:435–442.
14.
KestenSChaparroCScavuzzoM. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. J Heart Lung Transplant1997; 16:905–912.
15.
DusmetMMaurerJWintonT. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant1996; 159:948–954.
16.
SpeichRBoehlerAThurnheerR. Salvage therapy with mycophenolate mofetil for lung transplant bronchiolitis obliterans. Transplantation1997; 64:533–535.
17.
NairRVHuangXShorthouseR. Antiproliferative effect of rapamycin on growth factor stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo. Transplant Proc1997; 29:614–615.
18.
DiamondDAMichalskiJMLynchJP. Efficacy of total lymphoid irradiation for chronic allograft rejection following bliateral lung transplantation. Int J Radiat Oncol Biol Phys1998; 414:795–800.
19.
HaberalMOzdemirFNKayaS. Beneficial effect of plasmapheresis on the outcome of transplant patients. Transplant Proc1996; 284:2336.
20.
SlovisBSLoydJEKingLE. Photopheresis for chronic rejection of lung allografts. N Engl J Med1995; 332:962.
21.
O'HaganARStilwellPCArroligaA. Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplant. Chest1999; 115:1459–1462.
22.
SalernoCTParkSJKreykesNS. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg1999; 1776:1063–1069.
23.
VillanuevaJBhoradeSMRobinsonJA. Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant2000; 53:44–47.
24.
Dall'AmicoRLiviUMilanoA. Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection. Transplantation1995; 60:45–49.
25.
Dall'AmicoRMontiniGMurerL. Benefits of photopheresis in the treatment of heart transplant patients with multiple/refractory rejection. Transplant Proc1997; 29:609–611.
26.
GiuntiGSchurfeldKMaccheriniM. Photopheresis for recurrent acute rejection in cardiac transplantation. Transplant Proc1999; 31:128–129.
27.
Costanzo–NordinMRHubbellEAO'SullivanJ. Successful treatment of heart transplant rejection with photopheresis. Transplantation1992; 534:808–815.
28.
BarrMLMeiserBMEisenHJ. Photopheresis for the prevention of rejection in cardiac transplantation. N Engl J Med1998; 339:1744–1751.
29.
RoseEASmithCRPetrossianGA. Humoral immune responses after cardiac transplantation: Correlation with fata rejection and graft atherosclerosis. Surgery1989; 106:203–208.
30.
RatkovecRMHammondEHO'ConnellJB. Outcome of cardiac transplant recipients with a positive donor-specific cross-match-preliminary results with plasmapheresis. Transplantation1992; 544:651.
31.
HodgeEEKlingmanLLKooAP. Pretransplant removal of anti-HLA antibodies by plasmapheresis and continued suppression on cyclosporine based therapy after heart–kidney transplant. Transplant Proc1994; 265:2750–2751.
32.
RoseEABarrMLXuHe. Photochemotherapy in human heart transplant recipients at high risk for fatal rejection. Transplant1992; 11:746–750.
33.
ArmitageJMKormosRLStuartRS. Posttransplant lymphoproliferative disorder in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant1991; 10:877–886.
34.
ArisRMMaiaDMNeuringerIP. Post-transplantation lymphoproliferative disorder in the Epstein–Barr virus-naïve lung transplant recipient. Am J Respir Crit Care Med1996; 154:1712–1717.
35.
SchochODBoehlerASpeichR. Extracorporeal photochemotherapy for Epstein–Barr virus associated lymphoma after lung transplantation. Transplantation1999; 682:1056–1058.
36.
WolfeJTLessinSRSinghAH. Review of immunomodulation by photopheresis: Treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. Artif Organs1994; 18:888–897.
37.
VowelsBRCassinMBoufalMH. Extracorporeal photochemotherapy induces the production of tumor necrosis factor alpha by monocytes: Implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol1992; 98:686–692.
38.
PerezMEdelsonRLarocheL. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. J Invest Dermatol1989; 92:669–676.
39.
YooEKRookAHElenitsasR. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: Relevance to mechanism of therapeutic action. J Invest Dermatol1996; 107:235–242.
40.
GoodrichRPYerramNRTay–GoodrichBH. Selective inactivation of viruses in the presence of human platelets: UV sensitization with psoralen derivatives. Proc Natl Acad Sci USA1994;91:5552–5556.
